You are here: Industry Insights > funding

News List

India-based MedTel receives investment term sheet from Catalist-listed Metal Component Engineering (MCE, SGX:5DX) prnasia
July 28, 2021
Catalist-listed Metal Component Engineering Limited is pleased to announce that it has, through its subsidiary, Metal Precision Services Pte Ltd, entered into a term sheet to take an equity stake in MedTel Healthcare Private Limited.
AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round prnasia
July 20, 2021
Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of $26 million from Guardant Health, Inc., a leading precision oncology company.
ClinSpec Diagnostics reaches funding target of £3.5m pharmatimes
March 05, 2021
Glasgow-based ClinSpec Diagnostics has secured an additional £1.1m investment, reaching its round two funding target of £3.5m.
111, Inc. Announces Additional Round of New Capital Injection prnasia
December 28, 2020
111, Inc. announced the successful completion of new capital injection in its principal PRC subsidiary by a selected group of strategic and mission-driven investors.
Palleon Pharmaceuticals secures $100m in Series B funding pharmaceutical-technology
September 18, 2020
Palleon Pharmaceuticals has raised $100m in a Series B financing round to develop drugs targeting glycan-mediated immune regulation to treat cancer and inflammatory diseases.
CEPI calls for proposals to apply for COVID-19 vaccine funding europeanpharmaceuticalreview
May 08, 2020
CEPI has announced it is urging organisations to apply for funding for the development and manufacturing of potential COVID-19 vaccines.
Funding support for community pharmacy during coronavirus pharmatimes
April 03, 2020
As of this morning - Friday April 3 - the current recorded case count for COVID-19 (coronavirus) in the UK has hit 33,718, with 2,921 deaths.
NHS England expands funding of Roche’s Hemlibra for haemophilia A pharmaceutical-technology
August 23, 2019
NHS England has announced it will reimburse Hemlibra (emicizumab) for severe congenital haemophilia A patients without clotting protein factor VIII inhibitors.
Some of Most Common, Deadly Cancers Get the Least Research Money drugs
July 25, 2019
Many of the most common or deadliest cancers receive the least research funding from nonprofits, a new study finds.
Nonprofit Funding by Cancer Type Not Proportional to Cancer Burden drugs
July 22, 2019
Nonprofit funding by cancer type is not proportionate to the burden of individual cancers...

Previous page 1 2 3 4 5 6 Next page